EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cognitive Impairment and Brain Atrophy in Patients with Chronic Kidney Disease

Kazuhiko Tsuruya, Hisako Yoshida

Journal of Clinical Medicine · 28.02.2024 · 13 (5) · 1401

DOI: 10.3390/jcm13051401 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.02.2024. Verfasst von Kazuhiko Tsuruya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Nara Medical University, Kashihara 634-8521, Nara, Japan. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Japan, the aging of the population is rapidly accelerating, with an increase in patients with chronic kidney disease (CKD) and those undergoing dialysis. As a result, the number of individuals with cognitive impairment (CI) is rising, and addressing this issue has become an urgent problem. A notable feature of dementia in CKD patients is the high frequency of vascular dementia, making its prevention through the management of classical risk factors such as hypertension, diabetes mellitus, dyslipidemia, smoking, etc., associated with atherosclerosis and arteriosclerosis. Other effective measures, including the use of renin–angiotensin system inhibitors, addressing anemia, exercise therapy, and lifestyle improvements, have been reported. The incidence and progression of CI may also be influenced by the type of kidney replacement therapy, with reports suggesting that long-duration dialysis, low-temperature hemodialysis, peritoneal dialysis, and kidney transplantation can have a preferable effect on the preservation of cognitive function. In conclusion, patients with CKD are at a higher risk of developing CI, with brain atrophy being a contributing factor. Despite the identification of various preventive measures, the evidence substantiating their efficacy remains limited across all studies. Future expectations lie in large-scale randomized controlled trials.

Schlagwörter

Stichwörter der Autor:innen

brain atrophychronic kidney diseasecognitive impairmentdialysisexercise

Autor:innen und Institutionen

  • Department of Nephrology, Nara Medical University, Kashihara 634-8521, Nara, Japan.
  • Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka 545-8585, Osaka, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • JSPS KAKENHI

Zitieren

APA

Tsuruya, K., & Yoshida, H. (2024). Cognitive Impairment and Brain Atrophy in Patients with Chronic Kidney Disease. Journal of Clinical Medicine, 13(5), 1401. https://doi.org/10.3390/jcm13051401

Vancouver

Tsuruya K, Yoshida H. Cognitive Impairment and Brain Atrophy in Patients with Chronic Kidney Disease. Journal of Clinical Medicine. 2024;13(5):1401. doi:10.3390/jcm13051401

BibTeX
@article{Tsuruya2024,
  author = {Tsuruya, Kazuhiko and Yoshida, Hisako},
  title = {Cognitive Impairment and Brain Atrophy in Patients with Chronic Kidney Disease},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {5},
  pages = {1401},
  doi = {10.3390/jcm13051401}
}
Kostenlos starten →